IRIS
FREDIANI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.433
EU - Europa 30.251
AS - Asia 18.486
SA - Sud America 3.436
Continente sconosciuto - Info sul continente non disponibili 1.479
AF - Africa 1.019
OC - Oceania 68
AN - Antartide 1
Totale 91.173
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.686
IT - Italia 7.226
RU - Federazione Russa 6.242
SG - Singapore 5.963
GB - Regno Unito 5.689
CN - Cina 5.244
IE - Irlanda 2.869
BR - Brasile 2.812
VN - Vietnam 2.031
DE - Germania 1.678
FR - Francia 1.484
HK - Hong Kong 1.481
SE - Svezia 1.469
UA - Ucraina 1.318
KR - Corea 952
FI - Finlandia 927
BD - Bangladesh 755
IN - India 607
ZA - Sudafrica 472
CA - Canada 395
NL - Olanda 315
AR - Argentina 202
TR - Turchia 202
ES - Italia 190
IQ - Iraq 179
JP - Giappone 177
MX - Messico 176
PL - Polonia 163
CI - Costa d'Avorio 134
PK - Pakistan 117
EC - Ecuador 109
AT - Austria 107
CZ - Repubblica Ceca 107
ID - Indonesia 101
KE - Kenya 78
UZ - Uzbekistan 76
MA - Marocco 74
NG - Nigeria 74
VE - Venezuela 69
BE - Belgio 67
CO - Colombia 67
SA - Arabia Saudita 65
AU - Australia 59
CL - Cile 58
CH - Svizzera 56
IR - Iran 55
PH - Filippine 55
AE - Emirati Arabi Uniti 52
EG - Egitto 45
LT - Lituania 44
PY - Paraguay 42
JO - Giordania 40
MY - Malesia 40
JM - Giamaica 38
GR - Grecia 36
NP - Nepal 35
RO - Romania 35
TN - Tunisia 34
PE - Perù 33
IL - Israele 28
UY - Uruguay 27
DZ - Algeria 26
CR - Costa Rica 25
AZ - Azerbaigian 24
PT - Portogallo 23
DK - Danimarca 22
LB - Libano 21
KZ - Kazakistan 20
AL - Albania 19
BY - Bielorussia 19
ET - Etiopia 18
BG - Bulgaria 16
EE - Estonia 16
HU - Ungheria 16
LV - Lettonia 16
TW - Taiwan 16
EU - Europa 15
HN - Honduras 15
PS - Palestinian Territory 15
TH - Thailandia 15
DO - Repubblica Dominicana 14
KG - Kirghizistan 14
OM - Oman 13
PA - Panama 13
TT - Trinidad e Tobago 13
AM - Armenia 12
NO - Norvegia 12
RS - Serbia 12
SN - Senegal 12
BH - Bahrain 11
BO - Bolivia 11
GT - Guatemala 11
NI - Nicaragua 11
SK - Slovacchia (Repubblica Slovacca) 11
SV - El Salvador 11
CY - Cipro 10
SY - Repubblica araba siriana 10
HR - Croazia 9
KW - Kuwait 8
LY - Libia 8
Totale 89.544
Salva come PNG Salva come JPEG
Città #
Dallas 6.313
Southend 4.886
Singapore 3.591
Dublin 2.825
Ashburn 2.657
Fairfield 2.320
San Jose 2.034
Santa Clara 1.778
Milan 1.769
Moscow 1.718
Chandler 1.390
Hong Kong 1.370
Hefei 1.341
Council Bluffs 1.249
Woodbridge 1.185
Beijing 1.105
Jacksonville 998
Seoul 945
Wilmington 944
Houston 885
Seattle 874
Cambridge 790
Siena 763
Los Angeles 749
Rome 748
Menlo Park 716
Ann Arbor 650
Ho Chi Minh City 618
New York 605
The Dalles 551
Helsinki 521
Munich 518
Hanoi 487
Princeton 461
Lauterbourg 455
Johannesburg 418
Nanjing 318
São Paulo 276
Florence 267
Columbus 254
Buffalo 239
Bengaluru 212
Boardman 205
San Mateo 199
Chicago 187
Orem 176
San Diego 164
Redondo Beach 145
London 143
Shanghai 141
Frankfurt am Main 137
Abidjan 134
Turin 132
Figino 131
Dearborn 130
Warsaw 125
Tokyo 124
Montreal 115
Dong Ket 114
Lappeenranta 112
Turku 109
Atlanta 108
Nanchang 107
Düsseldorf 102
Naples 102
Toronto 95
Denver 94
Brooklyn 93
Chennai 93
Nuremberg 91
Phoenix 90
Da Nang 89
Haiphong 85
Rio de Janeiro 85
Shenyang 85
Guangzhou 82
Stockholm 82
Boston 81
Lancaster 81
San Francisco 81
Washington 80
Bologna 79
Málaga 74
Abuja 70
Baghdad 70
Mexico City 68
Tashkent 65
Belo Horizonte 64
Tianjin 64
Hebei 63
Vienna 63
Changsha 61
Poplar 60
Amsterdam 58
Portsmouth 56
Izmir 55
Jiaxing 55
Manchester 55
Olomouc 55
Brescia 54
Totale 58.511
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 920
A first update on mapping the human genetic architecture of COVID-19 605
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 594
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 537
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 512
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 496
Genetic mechanisms of critical illness in COVID-19 454
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 442
Ultrasound definition of subacromial chronic “fibro-adhesive” bursitis and its treatment via ultrasound guided hydrodilation: a prospective pilot study 436
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 413
An explainable model of host genetic interactions linked to COVID-19 severity 390
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 388
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 387
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 381
Pathogen-sugar interactions revealed by universal saturation transfer analysis 375
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 374
Antirheumatic agents in covid-19: is IL-6 the right target? 370
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 368
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 363
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 360
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 359
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 357
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 353
Angiogenesis in alkaptonuria 351
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 349
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 340
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 335
Bone mineral density in patients with systemic sclerosis. 330
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 329
Mapping the human genetic architecture of COVID-19 328
Peripheral biomarkers' panel for severe COVID-19 patients 325
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 323
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 322
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 322
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 322
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 321
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 320
A proteomic study of human osteoblastic cells proliferation and differentiation 318
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 316
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 315
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 314
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 310
Long-term effects of neridronate on human osteoblastic cell cultures 310
Spasmophilia and entrapment nerve syndrome comorbidities in fibromyalgic patients: a possible neuromuscular pain generator. 310
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 306
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 306
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 304
Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound 304
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 304
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 304
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 302
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 301
Comment on: longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica. 301
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 300
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 299
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 294
A randomized comparison of the acceleraded folinic acid and 5-fluorouracil versus the conventional 5-fluorouracil schedule in advanced colorectal cancer. Supportive care and quality of life 290
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 289
Efficacy of Cellfood's therapy (deutrosulfazyme) in fibromyalgia [Efficacia del trattamento con Cellfood (deutrosulfazyme) nella fibromialgia] 288
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 287
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 286
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 285
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 282
Clodronate in the management of different musculoskeletal conditions 282
Radiologists and rheumatologists on performing and reporting shoulder ultrasound: From disagreement to consensus 281
Ultrasound in the diagnosis of calcium pyrophosphate dihydrate deposition disease. A systematic literature review and a meta-analysis 279
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 278
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 276
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 275
Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk 273
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 273
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 272
Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: An ultrasonographic study 271
Efficacy of extracorporeal shock wave treatment in calcaneal enthesophytosis. 267
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 267
Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. 267
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 266
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)] 265
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 265
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 264
Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation 262
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 261
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 260
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 260
Prognostic bioindicators in severe COVID-19 patients 259
Serial KL-6 measurements in COVID-19 patients 256
Weekly oral alendronate in mevalonate kinase deficiency 254
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 254
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 252
Clodronate: New directions of use 251
Extracorporeal shock wave therapy in the treatment of inferior calcaneal enthesophytosis: outcome by fan-beam dual x ray absorptiometry (DXA). 250
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 250
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 249
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 249
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 247
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 246
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 246
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 245
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 245
SAT0315 Calcium Pyrophosphate Dihydrate Deposition Disease: A Proposal of New Ultrasonographic Criteria for CPP Identification in the Joints 243
Totale 32.336
Salva come PNG Salva come JPEG
Categoria #
all - tutte 267.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 267.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.567 0 0 307 350 260 176 195 201 272 459 476 871
2022/20235.445 361 434 683 722 439 1.077 253 442 509 152 221 152
2023/20245.237 208 158 482 288 257 1.282 1.566 198 48 137 162 451
2024/202514.668 560 781 1.643 796 1.560 860 733 885 1.087 731 1.430 3.602
2025/202638.208 2.538 5.281 5.036 4.395 6.464 1.430 4.023 1.130 1.366 1.881 1.370 3.294
2026/20274.375 2.084 1.256 1.035 0 0 0 0 0 0 0 0 0
Totale 91.173